Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank71
3Y CAGR-12.7%
5Y CAGR+28.3%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-12.7%/yr
vs +62.4%/yr prior
5Y CAGR
+28.3%/yr
Recent deceleration
Acceleration
-75.1pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
3.5x
Strong expansion
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $94.87M | -21.1% |
| 2024 | $120.26M | -15.2% |
| 2023 | $141.85M | -0.4% |
| 2022 | $142.49M | -5.5% |
| 2021 | $150.82M | +453.7% |
| 2020 | $27.24M | +34.2% |
| 2019 | $20.29M | -1.0% |
| 2018 | $20.49M | -15.5% |
| 2017 | $24.25M | +284.5% |
| 2016 | $6.31M | - |